Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Consulting Services RFPsConsulting Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More consulting services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Senior Advisor 2 for Biological Therapeutics Development…

U.S. Department Of Health And Human Services·Maryland

Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.

Closes in 4 days$30k – $60kRequest for Quotation
Get bids like this by emailBid source

Description

The NIH Blueprint Neurotherapeutics Network (BPN) seeks a senior‑level subject‑matter expert to serve on the External Oversight Committee (EOC) and advise on biologics drug discovery and development for nervous‑system indications. The consultant will provide strategic guidance, risk assessments, IND preparation support, and mentorship to the HEAL Initiative’s executive team. Work is performed primarily remotely with up to one in‑person NIH meeting per year and limited travel reimbursements. The award is a small‑business set‑aside, fixed‑price purchase order covering a base year (Nov 13 2026‑Nov 14 2027) and up to two optional years.

Attached files

Contact

Dave Romley(Contract Specialist)

[email protected]

Key dates

Opened
10/27/2026
Questions due
10/29/2026
Closes
11/5/2026
Duration
3 years

Last updated

Details

Type
Request for Quotation
Industry
Consulting Services
NAICS
541690
Solicitation №
7571PSQ00013

Budget estimate

$30,000 – $60,000

The contract is labor‑hour based with a maximum of 50 hours per year plus a $2,000 travel allowance. Assuming a fully‑burdened rate of $200‑$400 per hour (typical for senior scientific consultants), annual labor cost ranges from $10,000 to $20,000, resulting in a total potential spend of $30,000‑$60,000 over the three‑year maximum term (base year plus two options).

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Health And Human Services·Maryland

Top match · 93%

2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Health And Human Services·Maryland

89% match

ATT 1 Senior _Advisor_2026_Statement of Work - Biological therapeutics EOC Support- 7571PS27Q00017

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Health And Human Services·Maryland

86% match

Senior Advisor Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise for the NINDS

Closes 11/2/2026Opened 10/23/2026

U.S. Department Of Health And Human Services·Maryland

85% match

Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network

Closes 11/2/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

82% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

81% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

U.S. National Institutes of Health·United States of America

76% match

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Closes 6/23/2028Opened 8/28/2025

U.S. National Institutes of Health·United States of America

76% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

76% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

75% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

75% match

NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure ? National Coordinating Center (NCC) and National Data Management Center (NDMC)

Closes 1/24/2028Opened 9/10/2026

U.S. National Institutes of Health·United States of America

75% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

NYS Empire State Development·New York

75% match

NeuroCatalyst Commercialization Fund Administrator

Closes 11/18/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Closes 11/10/2026Opened 6/25/2026

U.S. Department Of Health And Human Services·Maryland

75% match

Clinical Research Support and Collaboration for NHGRI Protocols

Closes 11/13/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

74% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

74% match

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 12/29/2025

Pennsylvania Turnpike Commission·Pennsylvania

74% match

Healthcare Benefits Consultant Services

Closes 11/19/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

74% match

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)

Closes 6/12/2028Opened 11/24/2025

U.S. National Institutes of Health·United States of America

74% match

Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence

Closes 5/24/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

74% match

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

Closes 11/1/2026Opened 5/6/2026

U.S. National Institutes of Health·United States of America

74% match

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Closes 7/5/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

74% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

74% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026